FDA approves Avita's premarket approval supplement for Recell, shares rise 13%
The FDA has approved Avita Medical’s premarket approval supplement for the use of its Recell System for the treatment of full-thickness skin defects, according to a press release.Recell, a system which uses a small amount of a patient’s skin to prepare Spray-On Skin Cells, was first FDA-approved in 2018 for the treatment of severe burns. RECELL was limited to treating